Yahoo Finance • 26 days ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story
Yahoo Finance • last month
CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions platform positions it for long-term opp... Full story
Yahoo Finance • 2 months ago
Investing.com - BTIG has lowered its price target on CareDx, Inc (NASDAQ:CDNA) to $22.00 from $26.00 while maintaining a Buy rating on the stock, citing potential impacts from recent Medicare reimbursement proposals. The stock, currently t... Full story
Yahoo Finance • 2 months ago
EMERYVILLE, Calif., August 12, 2025--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Dr. Reginald Seeto and William... Full story
Yahoo Finance • 2 months ago
* CareDx (NASDAQ:CDNA [https://seekingalpha.com/symbol/CDNA]) has appointed Nathan Smith as its new chief financial officer. * Smith brings over 14 years of experience in molecular diagnostics, including senior roles at Myriad Genetics... Full story
Yahoo Finance • 2 months ago
CAREDX INC (NASDAQ:CDNA [https://www.chartmill.com/stock/quote/CDNA]) REPORTS Q2 2025 EARNINGS: MIXED RESULTS AMID REVENUE ADJUSTMENTS CareDx Inc, a precision medicine company focused on transplant diagnostics, reported its second-quarter... Full story
Yahoo Finance • 2 months ago
* CareDx press release [https://seekingalpha.com/pr/20191798-caredx-announces-second-quarter-2025-financial-results] (NASDAQ:CDNA [https://seekingalpha.com/symbol/CDNA]): Q2 Non-GAAP EPS of $0.10 misses by $0.02. * Reported revenue of... Full story
Yahoo Finance • 3 months ago
[Cooler for human organ on orange background] Talaj/iStock via Getty Images Following a ~38% sell-off in the previous session, CareDx (NASDAQ:CDNA [https://seekingalpha.com/symbol/CDNA]) traded higher on Friday after the company said it d... Full story
Yahoo Finance • 3 months ago
Introduction & Market Context CareDx, Inc. (NASDAQ:CDNA) presented its Q2 2024 financial results on July 31, 2024, revealing strong revenue growth and a return to profitability. The transplant diagnostics company reported significant impr... Full story
Yahoo Finance • 4 months ago
* CareDx (NASDAQ:CDNA [https://seekingalpha.com/symbol/CDNA]) has completed the repurchase of $50M of its common stock representing approximately 5% of outstanding shares, the company said on Tuesday. * Following the completion of the... Full story
Yahoo Finance • 5 months ago
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches o... Full story
Yahoo Finance • 7 months ago
All Patent Claims Asserted Against CareDx are Found to Be Invalid BRISBANE, Calif., February 25, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of... Full story
Yahoo Finance • 8 months ago
When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a high quality business to buy (at the right price) you can more than double your money! For example, the CareDx, Inc (NA... Full story
Yahoo Finance • 12 months ago
BRISBANE, Calif., October 11, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, hi... Full story
Yahoo Finance • last year
DOJ Concludes Investigation and Declines to Prosecute BRISBANE, Calif., October 08, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development,... Full story
Yahoo Finance • last year
BRISBANE, Calif., September 14, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,... Full story
Yahoo Finance • last year
BRISBANE, Calif., July 16, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transpla... Full story
Yahoo Finance • 2 years ago
BRISBANE, Calif., January 09, 2024--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for trans... Full story
Yahoo Finance • 2 years ago
CareDx Expands Reach of its Transplant Pharmacy Services by Offering NFT Patients Help in Navigating the Complexity of Immunosuppression Medications and Adherence BRISBANE, Calif., December 19, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq:... Full story
Yahoo Finance • 2 years ago
BRISBANE, Calif., November 02, 2023--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for tran... Full story